A new genetic target for Alzheimer’s treatments

About Us CRU Directors CRU Investigators Professionals Trials Recruiting ALS Autism Brain Tumour Dementia Epilepsy Intensive Care Unit Migraine Movement Disorders Multiple Sclerosis Neuromuscular Neuro-Surgery Stroke Patients PACT News Contact us FR A new genetic...

A look back at the advances of 2024

About Us CRU Directors CRU Investigators Professionals Trials Recruiting ALS Autism Brain Tumour Dementia Epilepsy Intensive Care Unit Migraine Movement Disorders Multiple Sclerosis Neuromuscular Neuro-Surgery Stroke Patients PACT News Contact us FR 2024 in review:...

Can Alzheimer’s disease be stopped before it starts?

About Us CRU Directors CRU Investigators Professionals Trials Recruiting ALS Autism Brain Tumour Dementia Epilepsy Intensive Care Unit Migraine Movement Disorders Multiple Sclerosis Neuromuscular Neuro-Surgery Stroke Patients PACT News Contact us FR The next phase of...

2023 Year in Review: Driving research in rare disease

2023: The CRU driving new research in rare disease  Sophie LorenzoDecember 19, 2023   As a leading Canadian centre in neurological research, the Clinical Research Unit (CRU) at The Neuro is always striving to make neurological and rare diseases treatable – and...

A new chapter in Alzheimer’s research

About Us CRU Directors CRU Investigators Professionals Trials Recruiting ALS Autism Brain Tumour Dementia Epilepsy Intensive Care Unit Migraine Movement Disorders Multiple Sclerosis Neuromuscular Neuro-Surgery Stroke Patients PACT News Contact us FR A new chapter in...